Home / SME Stocks / Zenith Drugs
Zenith Drugs: IPO, Share Price and Results Since Listing
Zenith Drugs listed on NSE Emerge on 27 February 2024 after an IPO at INR 79 a share. On 11 November 2026 the shares closed at INR 39.40, 50.13% below the issue price. For H2 FY2026 it reported revenue of INR 93 crore (+41.71% on a year earlier) and a profit after tax of INR 1.61 crore.
Key Facts
- IPO dates
- 19 February 2024 to 22 February 2024
- Issue price
- INR 79
- Issue size
- INR 40.68 crore
- Subscription
- 179.07 times
- Lead manager
- Gretex Corporate Services Limited
- Listing day
- opened at INR 110 (+39.24%), closed at INR 105.15 (+33.10%)
- Listed on NSE Emerge
- 27 February 2024
- Symbol
- ZENITHDRUG
- Latest close
- INR 39.40 on 11 November 2026
- Against issue price
- -50.13%
- Lot size now
- 800 shares (INR 31,520 at the latest close)
Results Filed With NSE
Standalone figures, INR crore. Change compares with the same period a year earlier.
| Period | Revenue | Change | Profit after tax | EPS (INR) | Filed | |
|---|---|---|---|---|---|---|
| H2 FY2026 | 93 | +41.71% | 1.61 | 0.94 | after listing | 15 June 2026 |
| FY2026 | 171.22 | +28.43% | 3.94 | 2.30 | after listing | 15 June 2026 |
| H1 FY2026 | 78.22 | – | 2.34 | 1.36 | after listing | 14 November 2025 |
| H2 FY2025 | 65.63 | – | 1.44 | 0.84 | after listing | 2 July 2025 |
| FY2025 | 133.32 | – | 7.16 | 4.18 | after listing | 2 July 2025 |
Promoter Holding
Promoter holding has moved from 69.98% on 25 February 2024 to 69.98% on 30 September 2026 (0 percentage points).
| As of | Promoters | Public |
|---|---|---|
| 30 September 2026 | 69.98% | 30.02% |
| 31 March 2026 | 69.98% | 30.02% |
| 30 September 2025 | 69.98% | 30.02% |
| 31 March 2025 | 69.98% | 30.02% |
| 30 September 2024 | 69.98% | 30.02% |
| 31 March 2024 | 69.98% | 30.02% |
| 25 February 2024 | 69.98% | 30.02% |
Anchor Lock-ins
| Lock-in | Ends |
|---|---|
| 30 days | 24 March 2024 |
| 90 days | 23 May 2024 |
Next Board Meeting
14 November 2026: Financial results
Sources: NSE Emerge filings (results XBRL, shareholding pattern, board meetings), NSE daily price files, and IPO records. Prices are not adjusted for bonus issues or splits.